NLRP3 and Immunodeficiency: Furthermore, by integrating findings from existing studies and our experimental results, we hypothesize that ALD patients exhibit an immune deficiency state characterized by sustained non‐specific inflammatory responses, which impairs their ability to activate the NLRP3 inflammasome postinfection, thereby compromising their antibacterial defences (Figure 10).